Meeting
Abstract Number: I4
SHM Converge 2022
Background: Diabetes is an exceedingly common disease encountered by medical trainees, with over 8 million hospitalizations in 2018 listing type 1 or type 2 diabetes as a diagnosis (1). Evidence supports continuing certain oral diabetes medications during admission when safe, reflected in recent consensus statements from professional societies (2,3). Nevertheless, oral medications are often held […]
Abstract Number: 149
SHM Converge 2023
Background: The effects of diabetes medications on COVID-19 hospitalization outcomes have not been consistent. We sought to determine the effect of metformin, DPP-4 inhibitors (DPP-4i), and insulin on admission to the intensive care unit (ICU), need for assisted ventilation, development of renal insufficiency, and mortality, in patients admitted with COVID-19 infection after controlling for clinical […]